Cost-Utility Analysis of Deep Brain Stimulation for Generalized and Cervical Dystonia: A Perspective from Brazilian Healthcare.

Objective: In the Brazilian public national healthcare system, botulinum toxin type A has traditionally been the sole treatment option for patients with dystonia. However, as of October 2022, deep brain stimulation (DBS) garnered positive recommendations for the condition. This study aims to assess the cost-effectiveness of DBS in treating adults with generalized and cervical dystonia within the Brazilian healthcare context, considering its recent inclusion.

Stakeholder value judgments in decision-making on the incorporation, financing, and allocation of new health technologies in limited-resource settings: a potential Brazilian approach.

Objective: To analyze the value judgments behind cost-benefit tradeoffs made by health stakeholders in deciding whether or not to incorporate new health technologies and how they should be financed and allocated in limited-resource settings in Brazil.

Method: From June 2009 to January 2010, a sample of stakeholders in the public and private health sector was identified and invited to complete an online survey consisting of two questionnaires: one collecting socio-demographic/professional information and one capturing resource allocation preferences in four hypothetical scenarios for the incorporation of new health technologies.

Results: A total of 193 respondents completed the survey; more than half were male (53.

A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population.

Background: The 6-dimensional health state short form (SF-6D) is a health preference measure used in economic evaluations of many treatments.

Objectives: To compare the results provided by the SF-6D index, when applied to a representative sample of the Brazilian population, using Brazilian and UK preference weights.

Methods: Five thousand individuals were assessed in the 5 regions of Brazil.

Internal Consistency of the SF-6D as a Health Status Index in the Brazilian Urban Population.

Objectives: To investigate the internal consistency of the SF-6D as a health status index in the Brazilian urban population.

Study Design: Cross-sectional population based study.

Methods: Five thousand individuals, older than the age of 15, were assessed in the five regions of the country.

Quality of life in a sample of Brazilian adults using the generic SF-12 questionnaire.

Objective: This study describes the summary scores of the Short Form-12 (SF-12) questionnaire, according to socio-demographic factors obtained in a probabilistic and representative sample of the Brazilian urban population.

Method: Five thousand (5,000) individuals, over the age of 15, were assessed in 16 capital cities, in the five regions of the country. The selection of households was random.

Perception of the value of generic drugs in São Paulo, Brazil.

The objective of this study was to assess the perceptions of opinion-leaders, patients and their accompanying family members or carers about generic drugs. Three groups of participants were surveyed: (i) 50 customers while they were visiting commercial pharmacies located in São Paulo city, Brazil, (ii) 25 patients and 25 companions while they were waiting at the university outpatient clinic, and (iii) 50 healthcare opinion-leaders from government, hospitals, health plans, academia, and pharmaceutical companies. The questions explored socio-demographic characteristics and perceptions regarding value attributes of generic drugs compared to brand name drugs.

Perceptions of the population regarding generic drugs in Brazil: a nationwide survey.

Background: Generic drugs (GDs) offer a way to reduce health spending without sacrificing quality. Despite this, there are doubts as to their acceptance by the population. This work aims to assess perceptions of GDs among the Brazilian population.